Comparison

Paederosidic acid European Partner

Item no. TMO-T5739-50mg
Manufacturer TargetMol
Amount 50mg
Category
Type Molecules
Specific against other
Purity 98.00%
Citations Yu P , Shi L , Song M , et al. Antitumor activity of paederosidic acid in human non-small cell lung cancer cells via inducing mitochondria-mediated apoptosis[J]. Chemico-Biological Interactions, 2017, 269:33-40.
Smiles [H][C]12[CH](O)C=C(COC(=O)SC)[C]1([H])[CH](O[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1O)OC=C2C(O)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 18842-98-3, BCL
Available
Bioactivity
Paederosidic acid has significant anti-tumor, anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain, and it up-regulates expressions of GAD 65, may be a promising future therapeutic agent for treatment of epilepsy.
MolWt
464.4
Pathway
Apoptosis
Receptor
Bcl-2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close